Sino Biopharmaceutical Ltd. | Income Statement
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
9,901
12,378
14,550
15,824
17,088
24,742
Cost of Goods Sold (COGS) incl. D&A
2,241
2,929
3,258
3,291
3,564
4,971
Gross Income
7,660
9,450
11,292
12,533
13,524
19,770
SG&A Expense
5,052
6,167
7,131
8,939
9,752
14,518
EBIT
2,658
3,349
4,199
-
3,773
5,252
Unusual Expense
5
36
45
83
89
102
Non Operating Income/Expense
831
991
1,049
115
462
8,305
Interest Expense
3
43
80
90
90
182
Pretax Income
1,899
2,464
3,119
3,743
4,838
13,537
Income Tax
355
440
533
555
625
825
Equity in Affiliates
238
337
325
-
-
-
Consolidated Net Income
1,782
2,361
2,911
3,188
4,213
12,713
Net Income
1,037
1,513
1,779
1,913
2,503
10,715
Net Income After Extraordinaries
1,037
1,513
1,779
1,913
2,503
10,715
Net Income Available to Common
1,037
1,513
1,779
1,913
2,503
10,715
EPS (Basic)
0.09
0.14
0.23
0.17
0.23
0.87
Basic Shares Outstanding
11,118
11,118
7,859
11,118
11,118
12,366
EPS (Diluted)
0.09
0.14
0.23
0.17
0.23
0.87
Diluted Shares Outstanding
11,118
11,118
7,859
11,118
11,118
12,366
EBITDA
2,882
3,609
4,552
3,939
4,142
6,618
Other Operating Expense
50
67
38
-
-
-
Non-Operating Interest Income
69
114
93
45
96
193
Minority Interest Expense
745
848
1,132
1,275
1,710
1,998
Equity in Affiliates (Pretax)
-
-
-
348
472
71
About Sino Biopharmaceutical
View Profile
